• Info
  • Insider Ownership

Insider Trading & Ownership of Matthew T. Wiley

Location
Rehovot
Summary
The estimated net worth of Matthew T. Wiley is at least $1,809,010 dollars as of 05 Feb 2026. Matthew T. Wiley is the Chief Commercial Officer of Definium Therapeutics, Inc. and owns shares of Definium Therapeutics, Inc. (DFTX) stock worth about $1.54M. Matthew T. Wiley is the Chief Commercial Officer of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $249.1K. Matthew T. Wiley is the Chief Commercial Officer of BioXcel Therapeutics, Inc. and owns shares of BioXcel Therapeutics, Inc. (BTAI) stock worth about $20.1K.
Signature
/s/Mark Sullivan, Attorney-in-Fact for Matthew T. Wiley
All Insider Reports
All Insider Reports

Notify me when Matthew T. Wiley files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Matthew T. Wiley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DFTX Definium Therapeutics, Inc. Chief Commercial Officer $1,539,873 03 Feb 2026
VYNE VYNE Therapeutics Inc. Chief Commercial Officer $249,081 30 Jun 2021
BTAI BioXcel Therapeutics, Inc. Chief Commercial Officer $20,056 17 Sep 2024

Insider Transactions Reported by Matthew T. Wiley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.